Our History

Home    >     About     >     Our History

Milestones

Throughout the brand's journey, there have been several pivotal moments that steered its course of growth. Explore these with us and then delve into all the products we have ever created.

2005

Medicalgorithmics foundation

Medicalgorithmics was established in 2005 to commercialize unique algorithmic solutions for ECG signal analysis. At the early stage, the company focused on research and development of the PocketECG prototype for cardiac telerehabilitation.

2009

First FDA and expansion into the US

In 2009, PocketECG system was approved for sales in the United States by the Food and Drug Administration (FDA), paving the way for Medicalgorithmics expansion into the US market.

2014

Debut on the Warsaw Stock Exchange

Shares of Medicalgorithmics are listed on the Warsaw Stock Exchange Main Market since 2014. Today, the company is also included in the sWIG80 index.

2022

Strategic partnership with Biofund

In 2022, Biofund became a major shareholder of Medicalgorithmics, bringing technological capabilities and financing in a move to unleash Medicalgorithmics potential. Thanks to this strategic partnership, Medicalgorithmics is well positioned to develop and capitalize on its cutting-edge solutions in the US and beyond.

2022

Merger with Kardiolytics

As a result of the strategic partnership with Biofund, Medicalgorithmics joined forces with Kardiolytics, US-based AI company specialized in cardiology. Kardiolytics developed the Virtual Cardiac Stress Test (VCAST), which stands out with its advanced cloud-based software and AI algorithms for segmentation, stenotic vessel reconstruction and analytics. We believe that AI-powered VCAST project can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead.

2023

Global AI solutions provider

The last 18 years witnessed an intense transformation of our group, becoming more innovative, specialized and global. We are now a global provider of AI-powered and noninvasive solutions for cardiac arrhythmia that help improve the health of patients around the world.

Where We Come From

Our journey started in 2005 when we introduced the innovative PocketECG CRS system for cardiac telerehabilitation. With over 15 years of experience, we have become experts at implementing software solutions, developing AI algorithms, and creating ECG monitoring devices that effectively address the unique needs of patients, physicians, and healthcare systems globally.

Our FDA approved software has been used daily in the US since 2009. This allowed us to collect and annotate the largest ECG database on the market (>2.5 billion annotated heartbeats).

 

In 2022 FDA approved next generation DeepRhythm Artificial Intelligence (DRAI) Software Platform. Built on TechBot experience to further reduce the time needed to generate a report while maintaining superior diagnostic yield. The DRAI platform has been built with predictive analytics in mind (presented at ACC). 

Our software platform and PocketECG are used to monitor close to 200k patients annually in 22 countries.

c3bac59ed42ff1bddefab8b7a4748b2f
cf2839cf4c1b0144503d969280e175dc

Who We Are

Today, we are a leading medical technology company developing advanced, breakthrough software solutions, cloud computing, machine learning, and providing telemedical services to thousands of patients worldwide.

We provide software, artificial intelligence, and cloud based solutions to healthcare systems, physicians, and medical technology companies across the globe.


Our commitment to innovation is showcased by our products, such as the latest generation artificial intelligence platform which is FDA approved for cardiac rhythm analysis (DeepRhythmAI), or our AI based CT analysis software for assessment of coronary artery stenosis and coronary vessel plaque analysis.

Where We're Headed

As we look to the future, our focus is on leveraging cutting-edge software technologies to revolutionize patient care. We are actively working on predictive analytics algorithms which will bring fully autonomous solutions to clinicians worldwide, improving patient care and outcomes.

Building on this vision, our objective is to create a seamless and efficient healthcare system that benefits both medical professionals and patients. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, saving precious time and increasing the chances of successful treatment. Through the utilization of cloud computing, we aim to facilitate real-time data exchange, enabling doctors to access critical patient information instantly, no matter their geographical location. By enhancing the decision-making process and reducing human errors, we are on a mission to reshape the global healthcare landscape, making it more proactive, personalized, and efficient.

0cb79cc6bb346285ea65e245a21d3036

Need more information?

Contact us
Print Friendly, PDF & EmailPobierz stronę jako PDF
Feed RSS

Share

About

Our company
About us
Our history
Management Team
Partners
Career
Work with us
Job offers
Application form
Press room
Contact for media
Media pack

Products

PocketECG
VCAST
DRAI
DRP
Kardiobeat.ai

R&D Services

Clinical Research

News

Investors

Reports and data
Financial data
Current reports
Financial reports
Strategy
Media
Presentations
Corporate calendar
Contact for investors
Stocks and bonds
Shareholders
Quotations
Dividend
Grants
Prospectus
Bonds
Corporate governance
General Meetings
Management Team
Corporate governance
Corporate documents

Contact

Contact us
Contact for investors
Contact for media
© 2024 Medicalgorithmics.com
Privacy Policy

DeepRhythm Platform (DRP)

Get Your Free Consultation, 
Custom Tailored To Your Needs.
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

The wait is almost over!

DRAI MARTINI study is set to be published soon. Be the first to know when it lands.
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Your submission was succesfull

Software

Get more information
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

VCAST

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

DeepRhythmAI (DRAI)

Get Your Free Consultation, 
Custom Tailored To Your Needs.
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Our company

About us

Our History

Management Team

Partners

Career

Work with us

Job offers

Recommend an employee

Application form